Expectations trend
FY2028 · fiscal year ending 2028-02-01 · fmp
Chewy (CHWY)
NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-11-05
$23.00-1.71%
Close 2026-11-05 · 1-day change
NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.06 → 1.07 EPS · FY ending Feb 1, 2028 · 15 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 15 to 15; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for CHWY yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Cash from operations at least $263.4 million | The company is expanding gross margin and increasing cash from operations. | Intact | cash from operations falls below $133.9 million | Cash from operations: $137.4M FY2026-Q2; GAAP. Published target: >=263.4 million USD. The stored target says 2025-Q4; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Sep 9, 2026137,400,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-02-01 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a profitable-growth business with a multi-year thesis built on expanding margins, better efficiency, and stronger cash flow. The thesis is intact, with recent financial performance in the top half of its industry, but confidence is medium and risk is elevated.
The valuation is expensive versus peers, with a 1.63 premium, while the expectations gap is negative at -0.13. The priced-in assessment is tagged as justified and fragility is low, but that does not remove the risk that expectations are difficult to meet.
Near-term results show progress: sales, adjusted EBITDA margin, and net income rose between 2026-Q1 and 2026-Q3, while gross margin and operating income also improved. Management’s priorities remain on track, and free cash flow reached a record in fiscal 2025, but a September earnings miss and a run of recent misses create execution risk.
The multi-year thesis depends on management continuing to expand margins, improve efficiency, and generate cash flow. Near term, a guidance cut on the next call would be a meaningful negative; stronger or weaker results and guidance from sector bellwethers could also shape the consumer-discretionary backdrop.
Over the next 1 to 3 years, CHWY’s operating progress supports an intact thesis, but its expensive valuation and recent earnings misses make continued delivery important. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| The company is expanding gross margin and increasing cash from operations. |
| Intact |
| gross margin falls below 29.6% (mid-cycle level) |
Gross margin: 30.36% FY2026-Q2; GAAP. Published target: >=30.1%. The target does not explicitly identify fiscal versus calendar quarters. Sep 9, 202630.364543 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 3 supplied quarters. Management reported: “"That performance underscores the durability of the Chewy model and gives us confidence in our ability to deliver continued profitable growth, expanding margins, and strong cash generation in 2026 and beyond.”” “Chewy Reaffirms Financial Outlook As discussed on our December 10, 2025 earnings call, Chewy’s long-term plan remains intact, our business momentum remains strong, and we remain firmly on track toward the long-term margin profile of 10% Adjusted EBITDA that we outlined at Investor Day.” Gross profit was $1.011 billion in 2026-Q2. Delivery assessment Nov 5, 2026 |
Net income growth to at least $94.8 million | Net income rose to $94.8 million in Q2 2026. | Intact | net income falls below $62.4 million | Net income: $80.5M FY2026-Q2; GAAP. Published target: >=94.8 million USD. The target does not explicitly identify fiscal versus calendar quarters. Sep 9, 202680,500,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth of at least 7.9% annually | A primary condition in Chewy's published investment case. The stated target is >=7.9% YoY. | Broken | YoY revenue growth falls below 7.9% next year | Revenue growth: 7.28% FY2026-Q2; GAAP. Published target: >=7.9% YoY. Reported actuals cannot certify a consensus target without an explicit period and accounting-basis binding. Sep 9, 20267.280459 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.09 → $1.07 · observed estimates
$14.45B → $14.44B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $1.09 | $14,445,318,430 | 14 / 19 |
| 2026-07-25 | $1.09 | $14,445,318,430 | 14 / 19 |
| 2026-07-26 | $1.09 | $14,445,318,430 | 14 / 19 |
| 2026-07-27 | $1.09 | $14,445,318,430 | 14 / 19 |
| 2026-07-28 | $1.09 | $14,445,318,430 | 14 / 19 |
| 2026-07-29 | $1.09 | $14,445,318,430 | 14 / 19 |
| 2026-07-30 | $1.09 | $14,441,127,531 | 14 / 19 |
| 2026-07-31 | $1.09 | $14,441,127,531 | 14 / 19 |
| 2026-08-01 | $1.09 | $14,441,127,531 | 14 / 19 |
| 2026-08-02 | $1.09 | $14,441,127,531 | 14 / 19 |
| 2026-08-03 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-04 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-05 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-06 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-07 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-08 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-09 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-10 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-11 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-12 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-13 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-14 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-15 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-16 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-17 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-18 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-19 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-20 | $1.08 | $14,434,327,531 | 14 / 19 |
| 2026-08-21 | $1.08 | $14,432,794,430 | 15 / 19 |
| 2026-08-22 | $1.08 | $14,432,794,430 | 15 / 19 |
| 2026-08-23 | $1.08 | $14,432,794,430 | 15 / 19 |
| 2026-08-24 | $1.08 | $14,432,794,430 | 15 / 19 |
| 2026-08-25 | $1.08 | $14,432,794,430 | 15 / 19 |
| 2026-08-26 | $1.08 | $14,432,794,430 | 15 / 19 |
| 2026-08-27 | $1.08 | $14,432,794,430 | 15 / 19 |
| 2026-08-28 | $1.08 | $14,426,939,466 | 15 / 19 |
| 2026-08-29 | $1.08 | $14,426,939,466 | 15 / 19 |
| 2026-08-30 | $1.08 | $14,426,939,466 | 15 / 19 |
| 2026-08-31 | $1.08 | $14,426,939,466 | 15 / 19 |
| 2026-09-01 | $1.08 | $14,426,939,466 | 15 / 19 |
| 2026-09-02 | $1.08 | $14,426,939,466 | 15 / 19 |
| 2026-09-03 | $1.08 | $14,426,967,466 | 15 / 19 |
| 2026-09-04 | $1.08 | $14,426,967,466 | 15 / 19 |
| 2026-09-05 | $1.08 | $14,426,967,466 | 15 / 19 |
| 2026-09-06 | $1.08 | $14,413,854,798 | 15 / 19 |
| 2026-09-07 | $1.08 | $14,413,854,798 | 15 / 19 |
| 2026-09-08 | $1.08 | $14,413,854,798 | 15 / 19 |
| 2026-09-09 | $1.08 | $14,413,855,630 | 15 / 19 |
| 2026-09-10 | $1.07 | $14,427,702,616 | 15 / 19 |
| 2026-09-11 | $1.07 | $14,430,734,910 | 15 / 19 |
| 2026-09-12 | $1.07 | $14,434,334,910 | 15 / 19 |
| 2026-09-13 | $1.07 | $14,434,334,910 | 15 / 19 |
| 2026-09-14 | $1.07 | $14,434,334,910 | 15 / 19 |
| 2026-09-15 | $1.07 | $14,434,334,910 | 15 / 19 |
| 2026-09-16 | $1.07 | $14,434,334,910 | 15 / 19 |
| 2026-09-17 | $1.07 | $14,434,334,910 | 15 / 19 |
| 2026-09-18 | $1.07 | $14,434,334,910 | 15 / 19 |
| 2026-09-19 | $1.06 | $14,434,334,910 | 15 / 19 |
| 2026-09-20 | $1.06 | $14,434,338,870 | 15 / 19 |
| 2026-09-21 | $1.06 | $14,434,338,870 | 15 / 19 |
| 2026-09-22 | $1.06 | $14,434,334,910 | 15 / 19 |
| 2026-09-23 | $1.06 | $14,434,334,910 | 15 / 19 |
| 2026-09-24 | $1.06 | $14,434,334,910 | 15 / 19 |
| 2026-09-25 | $1.06 | $14,434,334,910 | 15 / 19 |
| 2026-09-26 | $1.06 | $14,434,334,910 | 15 / 19 |
| 2026-09-27 | $1.06 | $14,434,334,910 | 15 / 19 |
| 2026-09-28 | $1.06 | $14,434,334,910 | 15 / 19 |
| 2026-09-29 | $1.06 | $14,434,334,910 | 15 / 19 |
| 2026-09-30 | $1.06 | $14,439,185,666 | 15 / 19 |
| 2026-10-01 | $1.06 | $14,439,174,910 | 15 / 19 |
| 2026-10-02 | $1.06 | $14,439,174,910 | 15 / 19 |
| 2026-10-03 | $1.06 | $14,439,174,910 | 15 / 19 |
| 2026-10-04 | $1.06 | $14,439,166,910 | 15 / 19 |
| 2026-10-05 | $1.06 | $14,439,166,910 | 15 / 19 |
| 2026-10-06 | $1.06 | $14,439,166,910 | 15 / 19 |
| 2026-10-07 | $1.06 | $14,439,166,910 | 15 / 19 |
| 2026-10-08 | $1.07 | $14,439,166,910 | 15 / 19 |
| 2026-10-09 | $1.07 | $14,439,166,910 | 15 / 19 |
| 2026-10-10 | $1.07 | $14,439,163,218 | 15 / 19 |
| 2026-10-11 | $1.07 | $14,439,163,218 | 15 / 19 |
| 2026-10-12 | $1.07 | $14,439,163,218 | 15 / 19 |
| 2026-10-13 | $1.07 | $14,439,163,218 | 15 / 19 |
| 2026-10-14 | $1.07 | $14,439,163,218 | 15 / 19 |
| 2026-10-15 | $1.07 | $14,439,163,218 | 15 / 19 |
| 2026-10-16 | $1.07 | $14,439,163,218 | 15 / 19 |
| 2026-10-17 | $1.07 | $14,439,163,218 | 15 / 19 |
| 2026-10-18 | $1.07 | $14,439,173,974 | 15 / 19 |
| 2026-10-19 | $1.07 | $14,439,173,974 | 15 / 19 |
| 2026-10-20 | $1.07 | $14,439,493,974 | 15 / 19 |
| 2026-10-21 | $1.07 | $14,439,493,974 | 15 / 19 |
| 2026-10-22 | $1.07 | $14,439,493,974 | 15 / 19 |
| 2026-10-23 | $1.07 | $14,439,493,974 | 15 / 19 |
| 2026-10-24 | $1.07 | $14,439,493,974 | 15 / 19 |
| 2026-10-25 | $1.07 | $14,439,493,974 | 15 / 19 |
| 2026-10-26 | $1.07 | $14,439,493,974 | 15 / 19 |
| 2026-10-27 | $1.07 | $14,439,493,974 | 15 / 19 |
| 2026-10-28 | $1.07 | $14,439,493,974 | 15 / 19 |
| 2026-10-29 | $1.07 | $14,439,493,974 | 15 / 19 |
| 2026-10-30 | $1.07 | $14,439,493,974 | 15 / 19 |
| 2026-10-31 | $1.07 | $14,439,493,974 | 15 / 19 |
| 2026-11-01 | $1.07 | $14,439,493,974 | 15 / 19 |
| 2026-11-02 | $1.07 | $14,439,493,974 | 15 / 19 |
| 2026-11-03 | $1.07 | $14,439,493,974 | 15 / 19 |
| 2026-11-04 | $1.07 | $14,439,493,974 | 15 / 19 |
| 2026-11-05 | $1.07 | $14,439,493,974 | 15 / 19 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 18 Buy / Strong Buy · 8 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Dec 9, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.